CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma

Inclusion Criteria: * 1.Male and female subjects with non-small cell lung carcinoma in patients with no available curative treatment options who have limited prognosis(≧3 months)with currently available therapies will be enrolled. * 2.The last cytotoxic drug, radiotherapy or surgery≧4 weeks. * 3.HB≧90g/L, ANC≧1.5×10e9/L, PLT≧80×10e9/L, TBIL≦1.5×upper limit of nomal, ALT/AST≦2.5×upper limit of nomal, ALT/AST≦5×upper limit of nomal if have liver metastasis, Cr≦1.5×upper limit of nomal or CCr≧60ml/min. Exclusion Criteria: * 1.Pregnancy or breastfeeding. * 2.Known HIV, HBV or HCV infection. * 3.Active antoimmune disease. * 4.History of severe immediate hypersensitivity to any of the biological products including penicillin. * 5.Severe psychiatric disorder which might interfere with the study treatment or examination. * 6.Chronic heart failure NYHA≧III. * 7.Simultaneous participation in another clinical trial within 4 weeks.